Adverse events during a placebo phase for inpatients with chronic schizophrenia

Biological Psychiatry

Volumn 50, Issue 7, 2001, Pages 487-492

  Van de Laar, Nicole ^a   Henter, Ioline ^b   Bartko, John J ^b   Wyatt, Richard Jed ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Adverse events; Placebo; Schizophrenia

Indexed keywords

PLACEBO;

ARTICLE; CONTROLLED STUDY; CONVALESCENCE; DOUBLE BLIND PROCEDURE; FEMALE; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RATING SCALE; RETROSPECTIVE STUDY; SCHIZOPHRENIA;

ANTIPSYCHOTIC AGENTS; CHRONIC DISEASE; ETHICS, MEDICAL; HUMANS; INPATIENTS; PLACEBO EFFECT; PSYCHIATRIC STATUS RATING SCALES; RECURRENCE; RETROSPECTIVE STUDIES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 0035477240     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(01)01225-2     Document Type: Article

References (27)

1. The Psychiatric Symptom Assessment Scale (PSAS)
2. Absconding: Outcome and risk
3. Risk and dangerousness
4. Injuries to research subjects. A survey of investigators
5. Sense and nonsense: An essay on schizophrenia research ethics
6. The risk of medication-free research
7. The rationale and ethics of medication-free research in schizophrenia
8. Research as an impetus to improved treatment
9. Neuroleptic withdrawal in schizophrenic patients. A review of the literature
10. Clinical research: A key to clinical training
11. Early antipsychotic response to resumption of neuroleptics in drug-free chronic schizophrenic patients
12. The assessment of suicide risk in the general hospital
13. A controlled study of satisfaction among psychobiology research patients
14. Time course of antipsychotic effects of neuroleptic drugs
15. The effect of psychobiological research on treatment outcome. A controlled study
16. Placebo controls: No news is good news
17. 'Due' and 'undue' inducements: On paying money to research subjects
18. Are stress questionnaires stressful
19. The placebo problem remains
20. Initial improvement as predictor of outcome of neuroleptic treatment
21. The brief psychiatric rating scale
22. Violent recidivism: Assessing predictive value
23. Familial differences between rapid neuroleptic response psychosis and delayed neuroleptic response psychosis
24. On social dangerousness of mental patients
25. Early response to haloperidol treatment in chronic schizophrenia
26. The long-term effects of placebo in patients with chronic schizophrenia